Corvair vs Cleerly LABS
AI Verdict
Choose Corvair if…
Choose Corvair if you need rapid, AI-assisted interpretation of standard 10-second resting diagnostic ECGs to quickly identify and categorize 35 cardiac determinations, including rhythm and morphology abnormalities. This tool is ideal for healthcare professionals seeking to enhance their diagnostic confidence and efficiency in acute care settings or routine cardiology evaluations where immediate ECG insights are critical.
View Corvair →Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) images to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is best suited for cardiologists and radiologists focused on personalized heart disease management, risk stratification, and tracking disease progression over time based on detailed anatomical and plaque burden assessments.
View Cleerly LABS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Corvair | Cleerly LABS |
|---|---|---|
| Pricing | Unknown | Per analysis |
| Deployment | Cloud, Mobile App | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CorvairCorvair (Tool A) focuses on ECG analysis, requiring only 4 leads and providing automated interpretations of 10-second ECGs, suggesting a streamlined and quick workflow. Cleerly LABS (Tool B), while web-based, deals with more complex CCTA imaging data and requires an on-site proxy for data transfer, which could introduce more complexity in setup and daily use.
Clinical Value
Cleerly LABSCleerly LABS (Tool B) offers a comprehensive assessment of coronary plaque (volume, type), stenosis, and ischemia detection, along with personalized risk assessment and tracking disease progression, aiming to prevent heart attacks. Corvair (Tool A) provides diagnostic assistance for ECGs with 35 cardiac determinations, which is valuable but less comprehensive in its long-term disease management scope.
Pricing & Value
Cleerly LABSCleerly LABS (Tool B) provides transparent pricing information, including a retail price and a discounted offer, allowing potential users to understand the cost upfront. Corvair (Tool A) requires contacting the vendor for pricing, which makes it difficult to assess its value proposition without further inquiry.
Enterprise Readiness
Cleerly LABSBoth tools are FDA-cleared, HIPAA compliant, and cloud-based with BAAs. However, Cleerly LABS (Tool B) explicitly highlights integration with PACS, RIS, and EHR systems via its Cleerly Proxy, which is a critical feature for seamless integration into existing hospital IT infrastructure. Corvair (Tool A) mentions ISO 42001 certification for its AI Management System but less detail on direct system integrations.
Innovation
Cleerly LABSCleerly LABS (Tool B) demonstrates higher innovation by leveraging AI for comprehensive coronary plaque characterization, 3D visualization, personalized risk assessment, and tracking disease progression from CCTA data. This goes beyond traditional CCTA interpretation to offer a more in-depth and prognostic view of atherosclerosis. Corvair (Tool A) provides AI-powered ECG analysis, which, while valuable, is a more established application of AI in cardiology.
Support & Docs
TieBoth AliveCor (for Corvair) and Cleerly (for Cleerly LABS) indicate offering dedicated customer support, clinical education, and training resources for their professional products. Without more granular details on the depth, responsiveness, or breadth of these services for each specific product, it is challenging to definitively choose a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Corvair | Cleerly LABS |
|---|---|---|
| Tool Name | Corvair | Cleerly LABS |
| Company | AliveCor | Cleerly |
| Primary Modality Analyzed | Resting diagnostic ECGs | Coronary CT angiography (CCTA) |
| Key Analysis Output | 35 cardiac determinations (14 rhythm, 21 morphology); AI-powered ECG analysis | Comprehensive coronary plaque assessment (volume, type); stenosis detection and quantification; ischemia detection (with Cleerly ISCHEMIA module); 3D visualization of coronary arteries |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Corvair and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring Corvair or Cleerly LABS
Backers
Who funded each tool's parent company.